National Comprehensive Cancer Network



NCCN Oncology Research Program (ORP)
NCCN and Pfizer Inc. Grant Opportunity - Submit by July 15, 2015
ORP Recent News
ORP Affiliate Research Consortium
ORP Scientific Publications
ORP for Industry
ORP Investigator Steering Committee
ORP Testimonials
Clinical Trials at NCCN Member Institutions
Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
ORP Grant History
Informed Consent Language Database
Points to Consider on the Best Practices for Biorepositories, Registries and Databases
ORP Disclosure Policy
NCCN Collaboration with the National Business Group on Health
NCCN Health Information Technology Licensees

NCCN Research & Business Resources

Updates to NCCN Guidelines for Antiemesis v 4.2009

The NCCN Clinical Practice Guidelines in Oncology™ for Antiemesis have been updated and published. New to the Guideline are emesis prevention recommendations for oral chemotherapy regimens. Also added to the Guideline are the emetogenic potential of oral antineoplastic agents.